Researchers aimed to describe the most common symptoms of long COVID and the progression of symptoms over time. They presented their findings at IDWeek 2023 in Boston, Massachusetts.
Rates of clinically diagnosed depression and anxiety without depression increased between 2017 and 2021, especially during the COVID-19 pandemic, according to recent cohort study results published in JAMA...
Researchers conducted a randomized trial to evaluate the impact of mindfulness-based stress reduction on depression and quality of life in older adults living with HIV and cognitive impairment.
In a long-term follow-up to SIERRA, a multicenter, randomized, controlled phase 3 study, researchers found that patients 55 years of age or older with active relapsed or refractory acute myeloid leukemia...
Although the immunotherapy plus chemotherapy did not improve disease-free survival (DFS) in newly diagnosed, high-risk patients with endometrial cancer, the combination therapy did improve DFS for patients...
Two randomized, double-blind studies demonstrated that a new antipsychotic treatment for adult patients with schizophrenia may lead to a meaningful reduction in symptoms.
Researchers who developed a meta-analysis of 19 randomized controlled trials found a statistically significant improvement in overall survival with sorafenib when compared with placebo for patients with...
Researchers sought to determine the reliability of the use of transvaginal ultrasonography triage to diagnose endometrial cancer in patients who are Black and at risk for the disease.
Researchers conducted a cross-sectional clinical trial with 8920 participants to evaluate whether a multitarget stool RNA test could serve as a noninvasive tool for detecting colorectal cancer, offering an...
